Free Trial

JBS (JBS) Financials

JBS logo
$12.44 +0.04 (+0.31%)
Closing price 11/11/2026 03:59 PM Eastern
Extended Trading
$12.50 +0.06 (+0.46%)
As of 11/11/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for JBS

Annual Income Statements for JBS

This table shows JBS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-199 2,692 2,024
Consolidated Net Income / (Loss)
-132 1,968 2,230
Net Income / (Loss) Continuing Operations
-162 2,492 1,839
Total Pre-Tax Income
-260 2,362 2,620
Total Operating Income
1,084 3,947 4,160
Total Gross Profit
7,967 11,588 11,299
Total Revenue
72,918 79,669 86,184
Operating Revenue
72,918 79,669 86,184
Total Cost of Revenue
65,073 61,217 74,960
Operating Cost of Revenue
65,073 61,217 74,960
Total Operating Expenses
6,909 14,505 7,176
Selling, General & Admin Expense
6,909 7,106 7,176
Total Other Income / (Expense), net
-1,353 -1,585 -1,556
Interest Expense
1,938 - 2,121
Interest & Investment Income
584 - 565
Other Income / (Expense), net
9.54 -1,585 17
Income Tax Expense
-256 -127 781
Net Income / (Loss) Attributable to Noncontrolling Interest
-67 -201 -205
Basic Earnings per Share
($0.19) - $1.89
Weighted Average Basic Shares Outstanding
- - 1.07B
Diluted Earnings per Share
($0.19) - $1.89
Weighted Average Diluted Shares Outstanding
- - 1.07B
Weighted Average Basic & Diluted Shares Outstanding
- - 1.07B

Quarterly Income Statements for JBS

This table shows JBS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q3 2025 Q2 2026 Q3 2026
Period end date 6/30/2025 9/30/2025 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
528 581 -174 164
Consolidated Net Income / (Loss)
594 644 -96 189
Net Income / (Loss) Continuing Operations
444 452 -180 177
Total Pre-Tax Income
736 815 -222 196
Total Operating Income
1,105 1,219 -229 516
Total Gross Profit
2,833 2,972 2,588 2,414
Total Revenue
20,998 22,597 23,102 22,738
Operating Revenue
20,998 22,597 23,102 22,738
Total Cost of Revenue
18,181 19,637 21,312 20,339
Operating Cost of Revenue
18,181 19,637 21,312 20,339
Total Operating Expenses
1,729 1,770 2,019 1,914
Selling, General & Admin Expense
1,729 1,770 1,999 1,914
Total Other Income / (Expense), net
-376 -408 28 -309
Interest Expense
446 611 - 473
Interest & Investment Income
69 203 - 164
Income Tax Expense
284 342 -144 15
Net Income / (Loss) Attributable to Noncontrolling Interest
-66 -63 -5.93 -24
Basic Earnings per Share
$0.48 $0.52 - $0.15
Weighted Average Basic Shares Outstanding
- - 1.07T 1.07T
Diluted Earnings per Share
$0.48 $0.52 - $0.15
Weighted Average Diluted Shares Outstanding
- - 1.07T 1.07T
Weighted Average Basic & Diluted Shares Outstanding
- - 1.07T 1.07T

Annual Cash Flow Statements for JBS

This table details how cash moves in and out of JBS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
2,017 4,157 4,353
Net Cash From Operating Activities
2,017 4,157 4,538
Net Cash From Continuing Operating Activities
2,017 4,157 4,538
Net Income / (Loss) Continuing Operations
-132 1,968 2,230
Consolidated Net Income / (Loss)
-132 1,968 2,230
Depreciation Expense
2,149 2,190 2,309
Net Cash From Investing Activities
0.00 0.00 -186
Net Cash From Continuing Investing Activities
0.00 0.00 -186
Purchase of Investments
0.00 0.00 -186
Net Cash From Financing Activities
0.00 0.00 0.00
Net Cash From Continuing Financing Activities
0.00 0.00 0.00
Cash Interest Paid
1,288 1,487 1,302
Cash Interest Received
187 192 188

Quarterly Cash Flow Statements for JBS

This table details how cash moves in and out of JBS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q3 2026
Period end date 9/30/2025 9/30/2026
Net Change in Cash & Equivalents
2,659 3,781
Net Cash From Operating Activities
6,106 5,507
Net Cash From Continuing Operating Activities
6,106 5,507
Net Income / (Loss) Continuing Operations
644 189
Consolidated Net Income / (Loss)
644 189
Depreciation Expense
584 660
Non-Cash Adjustments To Reconcile Net Income
6,239 4,419
Changes in Operating Assets and Liabilities, net
-1,361 239
Net Cash From Investing Activities
57 57
Net Cash From Continuing Investing Activities
57 57
Net Cash From Financing Activities
-3,504 -1,783
Net Cash From Continuing Financing Activities
-3,504 -1,783
Issuance of Debt
4,961 1,435
Cash Interest Received
61 43

Annual Balance Sheets for JBS

This table presents JBS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets
40,685 45,156
Total Current Assets
-3,898 18,438
Cash & Equivalents
5,750 4,565
Short-Term Investments
- 156
Accounts Receivable
3,736 4,232
Inventories, net
5,016 6,107
Other Current Assets
289 2,260
Plant, Property, & Equipment, net
11,781 13,646
Plant, Property & Equipment, gross
- 13,646
Total Noncurrent Assets
11,471 11,152
Long-Term Investments
38 172
Goodwill
5,417 5,853
Intangible Assets
1,803 1,826
Noncurrent Deferred & Refundable Income Taxes
2,064 547
Other Noncurrent Operating Assets
2,149 2,755
Total Liabilities & Shareholders' Equity
34,582 45,156
Total Liabilities
11,219 34,499
Total Current Liabilities
8,544 11,542
Short-Term Debt
729 833
Accounts Payable
5,466 6,510
Current Deferred & Payable Income Tax Liabilities
233 288
Other Taxes Payable
520 1,560
Other Current Liabilities
1,237 1,216
Total Noncurrent Liabilities
2,675 24,092
Long-Term Debt
- 20,257
Capital Lease Obligations
- 1,412
Noncurrent Deferred & Payable Income Tax Liabilities
1,095 1,577
Noncurrent Employee Benefit Liabilities
- 288
Other Noncurrent Operating Liabilities
1,580 366
Total Equity & Noncontrolling Interests
23,363 9,523
Total Preferred & Common Equity
22,323 8,704
Total Common Equity
22,323 8,765
Common Stock
13,178 35
Retained Earnings
- 2,086
Other Equity Adjustments
9,145 6,644
Noncontrolling Interest
1,040 819

Quarterly Balance Sheets for JBS

This table presents JBS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2026 Q3 2026
Period end date 6/30/2026 9/30/2026
Total Assets
45,838 47,078
Total Current Assets
17,757 18,650
Cash & Equivalents
3,469 4,149
Short-Term Investments
118 89
Accounts Receivable
3,555 3,274
Inventories, net
6,996 7,447
Other Current Assets
2,361 2,295
Plant, Property, & Equipment, net
14,416 14,614
Plant, Property & Equipment, gross
14,416 14,614
Total Noncurrent Assets
11,529 11,602
Long-Term Investments
226 214
Goodwill
5,984 5,993
Intangible Assets
1,785 1,755
Noncurrent Deferred & Refundable Income Taxes
656 699
Other Noncurrent Operating Assets
2,879 2,942
Total Liabilities & Shareholders' Equity
45,838 47,078
Total Liabilities
35,584 36,708
Total Current Liabilities
11,583 11,936
Short-Term Debt
1,335 1,421
Accounts Payable
6,260 6,373
Current Deferred & Payable Income Tax Liabilities
123 187
Other Taxes Payable
1,378 1,568
Other Current Liabilities
1,291 1,193
Total Noncurrent Liabilities
25,197 25,965
Long-Term Debt
21,316 22,187
Capital Lease Obligations
1,426 1,481
Noncurrent Deferred & Payable Income Tax Liabilities
1,600 1,621
Noncurrent Employee Benefit Liabilities
338 229
Other Noncurrent Operating Liabilities
376 324
Total Equity & Noncontrolling Interests
9,059 9,177
Total Preferred & Common Equity
8,224 8,331
Total Common Equity
8,224 8,085
Common Stock
42 42
Retained Earnings
118 283
Other Equity Adjustments
8,064 7,761
Noncontrolling Interest
835 846

Annual Metrics And Ratios for JBS

This table displays calculated financial ratios and metrics derived from JBS's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 0.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00
Growth Metrics
- - -
Profitability Metrics
- - -
Net Operating Profit after Tax (NOPAT)
759 4,159 2,920
Return On Investment Capital (ROIC_SIMPLE)
- 17.26% 10.90%
Earnings before Interest and Taxes (EBIT)
1,094 2,362 4,177
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,243 4,551 6,485
Valuation Ratios
- - -
Leverage & Solvency
- - -
Liquidity Ratios
- - -
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 726 2,724
Efficiency Ratios
- - -
Capital & Investment Metrics
- - -
Invested Capital
0.00 3,433 3,629
Increase / (Decrease) in Invested Capital
0.00 3,433 196
Book Value per Share
$0.00 $0.00 $23.25
Tangible Book Value per Share
$0.00 $0.00 $16.07
Total Capital
0.00 24,092 26,798
Total Debt
0.00 729 1,134
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
0.00 -5,060 -3,808
Capital Expenditures (CapEx)
0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -17,464 -17,781
Debt-free Net Working Capital (DFNWC)
0.00 -11,714 -13,057
Net Working Capital (NWC)
0.00 -12,442 -14,191
Net Nonoperating Expense (NNE)
891 2,192 690
Net Nonoperating Obligations (NNO)
0.00 -19,930 -22,034
Total Depreciation and Amortization (D&A)
2,149 2,190 2,309
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.89
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.07B
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.89
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.07B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.07B
Normalized Net Operating Profit after Tax (NOPAT)
759 2,763 2,920
Debt Service Ratios
- - -
Payout Ratios
- - -

Quarterly Metrics And Ratios for JBS

This table displays calculated financial ratios and metrics derived from JBS's official financial filings.

Metric Q2 2025 Q3 2025 Q2 2026 Q3 2026
Period end date 6/30/2025 9/30/2025 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 0.00 1,070,929,187,000.00 1,071,859,412,000.00
DEI Adjusted Shares Outstanding
0.00 0.00 1,070,929,187,000.00 1,071,859,412,000.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 0.00
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% 10.02% 0.62%
EBITDA Growth
0.00% 0.00% -118.15% -34.74%
EBIT Growth
0.00% 0.00% -118.15% -57.64%
NOPAT Growth
0.00% 0.00% -123.60% -32.39%
Net Income Growth
0.00% 0.00% -116.18% -70.68%
EPS Growth
0.00% 0.00% 0.00% -71.15%
Operating Cash Flow Growth
0.00% 0.00% 0.00% -9.81%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 7.62% 0.00% -1.58%
EBITDA Q/Q Growth
0.00% 63.16% 0.00% 686.69%
EBIT Q/Q Growth
0.00% 10.31% 0.00% 357.44%
NOPAT Q/Q Growth
0.00% 4.22% 0.00% 398.60%
Net Income Q/Q Growth
0.00% 8.38% 0.00% 296.37%
EPS Q/Q Growth
0.00% 8.33% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 1.40%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.94%
Profitability Metrics
- - - -
Gross Margin
13.49% 13.15% 11.20% 10.62%
EBITDA Margin
5.26% 7.98% -0.87% 5.18%
Operating Margin
5.26% 5.39% -0.99% 2.27%
EBIT Margin
5.26% 5.39% -0.87% 2.27%
Profit (Net Income) Margin
2.83% 2.85% -0.42% 0.83%
Tax Burden Percent
80.69% 79.00% 43.31% 96.29%
Interest Burden Percent
66.65% 66.88% 110.73% 37.99%
Effective Tax Rate
38.61% 42.00% 0.00% 7.42%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
678 707 -160 478
NOPAT Margin
3.23% 3.13% -0.69% 2.10%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% -0.70% 3.15%
Return On Investment Capital (ROIC_SIMPLE)
- - -0.48% 1.40%
Cost of Revenue to Revenue
86.59% 86.90% 92.25% 89.45%
SG&A Expenses to Revenue
8.24% 7.83% 8.65% 8.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
8.24% 7.83% 8.74% 8.42%
Earnings before Interest and Taxes (EBIT)
1,105 1,219 -201 516
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,105 1,803 -201 1,177
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.00 1,543.05 1,496.68
Price to Tangible Book Value (P/TBV)
0.00 0.00 27,854.62 35,798.51
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 8.44% 8.86%
Earnings Yield
0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 466.20 440.48
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 2,540.11 2,751.69
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.00 2.66 2.73
Long-Term Debt to Equity
0.00 0.00 2.51 2.58
Financial Leverage
0.00 0.00 2.01 2.00
Leverage Ratio
0.00 0.00 5.06 5.13
Compound Leverage Factor
0.00 0.00 5.60 1.95
Debt to Total Capital
0.00% 0.00% 72.66% 73.22%
Short-Term Debt to Total Capital
0.00% 0.00% 4.03% 4.15%
Long-Term Debt to Total Capital
0.00% 0.00% 68.63% 69.07%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 2.52% 2.47%
Common Equity to Total Capital
0.00% 0.00% 24.82% 23.60%
Debt to EBITDA
0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00
Altman Z-Score
0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - -
Current Ratio
0.00 0.00 1.53 1.56
Quick Ratio
0.00 0.00 0.62 0.63
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 -27,427 -27,044
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 -57.21
Operating Cash Flow to Interest Expense
0.00 9.99 0.00 11.65
Operating Cash Flow Less CapEx to Interest Expense
0.00 9.99 0.00 11.65
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - -
Invested Capital
0.00 0.00 27,267 27,522
Invested Capital Turnover
0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 0.00 27,267 27,522
Enterprise Value (EV)
0.00 0.00 12,711,609 12,122,776
Market Capitalization
0.00 0.00 12,690,511 12,101,293
Book Value per Share
$0.00 $0.00 $0.01 $0.01
Tangible Book Value per Share
$0.00 $0.00 $0.00 $0.00
Total Capital
0.00 0.00 33,135 34,266
Total Debt
0.00 0.00 24,076 25,089
Total Long-Term Debt
0.00 0.00 22,741 23,668
Net Debt
0.00 0.00 20,263 20,637
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 3,922 3,898
Debt-free Net Working Capital (DFNWC)
0.00 0.00 7,509 8,135
Net Working Capital (NWC)
0.00 0.00 6,174 6,714
Net Nonoperating Expense (NNE)
84 63 -64 289
Net Nonoperating Obligations (NNO)
0.00 0.00 18,208 18,345
Total Depreciation and Amortization (D&A)
0.00 584 0.00 660
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.15
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.07T 1.07T
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.15
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.07T 1.07T
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.07T 1.07T
Normalized Net Operating Profit after Tax (NOPAT)
678 707 -160 478
Normalized NOPAT Margin
3.23% 3.13% -0.69% 2.10%
Pre Tax Income Margin
3.51% 3.61% -0.96% 0.86%
Debt Service Ratios
- - - -
EBIT to Interest Expense
2.48 1.99 0.00 1.09
NOPAT to Interest Expense
1.52 1.16 0.00 1.01
EBIT Less CapEx to Interest Expense
0.00 1.99 0.00 1.09
NOPAT Less CapEx to Interest Expense
0.00 1.16 0.00 1.01
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

JBS’ second-quarter 2026 results show strong revenue growth but a sharp deterioration in profitability. Revenue increased 10.0% year over year to $23.1 billion, but higher operating costs and expenses more than offset the increase. The company’s results declined from a $528.1 million profit attributable to common shareholders in Q2 2025 to a $174.2 million loss in Q2 2026.

  • Revenue growth remained robust: Operating revenue rose approximately 10.0% year over year, indicating continued demand across JBS’ businesses.
  • Liquidity was reasonably strong: JBS held $3.5 billion in cash and equivalents and $17.8 billion in current assets against $11.6 billion in current liabilities, implying a current ratio of roughly 1.5.
  • Working-capital resources were substantial: Accounts receivable and inventories totaled approximately $10.6 billion, providing operating support, although inventory levels also create execution and pricing risks.
  • The balance sheet remained asset-rich: JBS reported $45.8 billion in total assets, including $14.4 billion of net property, plant and equipment that supports its processing and production operations.
  • Noncontrolling interests were meaningful: Noncontrolling interests totaled $834.8 million, which affects the portion of consolidated earnings attributable to JBS common shareholders.
  • Gross-margin pressure was significant: Gross profit fell 8.6% to $2.6 billion despite higher revenue. Gross margin declined to approximately 11.2% from 13.5% a year earlier.
  • Operating profitability turned negative: Operating income dropped from $1.1 billion in Q2 2025 to a $228.7 million operating loss in Q2 2026. Operating margin declined from roughly 5.3% to negative 1.0%.
  • Expenses grew faster than revenue: Selling, general and administrative expense increased 15.6% to nearly $2.0 billion, outpacing the company’s 10.0% revenue growth.
  • Net losses increased at the shareholder level: JBS recorded a $174.2 million loss attributable to common shareholders, compared with $528.1 million of earnings in the prior-year quarter. The company also reported a $180.2 million loss from continuing operations.
  • Leverage remains elevated: Long-term debt, short-term debt and capital lease obligations totaled approximately $24.1 billion, while total liabilities reached $35.6 billion. Debt and lease obligations therefore remain a major financial consideration, particularly while operating income is negative.

Overall, the quarter suggests that JBS is growing sales without currently converting that growth into profits. The key issue for investors is whether gross margins recover and operating expenses normalize. Until that occurs, the company’s sizable debt burden and weaker earnings could limit financial flexibility despite its substantial liquidity and asset base.

11/12/26 01:28 AM ETAI Generated. May Contain Errors.

JBS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, JBS's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

JBS's net income appears to be on an upward trend, with a most recent value of $2.23 billion in 2025, compared with -$131.74 million in 2023. The previous period was $1.97 billion in 2024. Check out JBS's forecast to explore projected trends and price targets.

JBS's total operating income in 2025 was $4.16 billion, based on the following breakdown:
  • Total Gross Profit: $11.30 billion
  • Total Operating Expenses: $7.18 billion

Over the last 2 years, JBS's total revenue changed from $72.92 billion in 2023 to $86.18 billion in 2025, a change of 18.2%.

In the past 1 quarters, JBS's cash and equivalents has ranged from $3.47 billion in Q2 2026 to $4.15 billion in Q3 2026, and is currently $4.15 billion as of their latest financial filing in Q3 2026.

JBS had total debt of $1.13 billion at the end of 2025, a 55.7% increase from 2024, and none in 2023.

Over the last 2 years, JBS's book value per share changed from 0.00 in 2023 to 23.25 in 2025, a change of 2,325.1%.



Financial statements for NYSE:JBS last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners